SpyGlass Pharma, Inc. (SGP)
NASDAQ: SGP · Real-Time Price · USD
22.81
-0.84 (-3.57%)
At close: Apr 28, 2026, 4:00 PM EDT
23.00
+0.20 (0.86%)
After-hours: Apr 28, 2026, 4:10 PM EDT
SpyGlass Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
| Selling, General & Admin | 12.27 | 7.08 |
| Research & Development | 29.18 | 19.98 |
| Operating Expenses | 41.45 | 27.06 |
| Operating Income | -41.45 | -27.06 |
| Interest & Investment Income | 3.11 | 1.32 |
| Other Non Operating Income (Expenses) | -1.53 | -3.42 |
| Pretax Income | -39.87 | -29.16 |
| Net Income | -39.87 | -29.16 |
| Net Income to Common | -39.87 | -29.16 |
| Shares Outstanding (Basic) | 2 | 2 |
| Shares Outstanding (Diluted) | 2 | 2 |
| Shares Change (YoY) | 23.98% | - |
| EPS (Basic) | -17.98 | -16.31 |
| EPS (Diluted) | -17.98 | -16.31 |
| Free Cash Flow | -33.49 | -24.02 |
| Free Cash Flow Per Share | -15.11 | -13.43 |
| EBITDA | -40.84 | -26.79 |
| D&A For EBITDA | 0.61 | 0.27 |
| EBIT | -41.45 | -27.06 |
Source: S&P Capital IQ. Standard template.
Financial Sources.